Pyc Therapeutics
Clinical trials sponsored by Pyc Therapeutics, explained in plain language.
-
Experimental eye drug hopes to slow inherited blindness
Disease control Recruiting nowThis study tests a new medicine called PYC-001, given as an injection into the eye, for people with a rare genetic condition (OPA1 mutation) that causes vision loss. The main goal is to check safety and find the best dose. About 18 adults will receive either one dose or three dos…
Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New eye drug hopes to slow blindness in rare genetic disease
Disease control Recruiting nowThis study tests an experimental drug called VP-001 for people with a rare inherited eye disease that causes vision loss (retinitis pigmentosa linked to the PRPF31 gene). The drug is injected into the eye and aims to slow or stop further vision decline. Sixteen adults who have al…
Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC